Cigna Group (NYSE:CI) Stock Rating Upgraded by Sanford C. Bernstein

Cigna Group (NYSE:CI) was upgraded by Sanford C. Bernstein from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Thursday, Marketbeat Ratings reports. The firm presently has a $358.00 price objective on the health services provider’s stock. Sanford C. Bernstein’s price target points to a potential upside of 37.28% from the company’s current price.

Other equities research analysts have also recently issued reports about the company. Weiss Ratings restated a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. Truist Financial lifted their price target on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Jefferies Financial Group upped their price objective on Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Leerink Partners raised their price objective on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research note on Friday, February 6th. Finally, Barclays lowered their target price on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research note on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $333.11.

Cigna Group Stock Performance

CI opened at $260.79 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The firm has a market cap of $68.73 billion, a P/E ratio of 11.76, a price-to-earnings-growth ratio of 0.91 and a beta of 0.27. The business’s fifty day moving average is $280.01 and its 200-day moving average is $283.29.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Insider Transactions at Cigna Group

In other news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

Several institutional investors have recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in shares of Cigna Group during the 4th quarter worth approximately $1,019,790,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Cigna Group by 13,333.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after acquiring an additional 3,141,844 shares during the period. Capital Research Global Investors boosted its stake in Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after acquiring an additional 1,855,897 shares in the last quarter. Dodge & Cox boosted its stake in Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after acquiring an additional 1,833,389 shares in the last quarter. Finally, Boston Partners grew its holdings in Cigna Group by 314.6% in the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock worth $450,856,000 after purchasing an additional 1,243,056 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.